Physician profile
James Battle
NPI 1407957160
$2,912.28
in general payments reported to CMS, 2019-2025
21 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $186 · 2021: $328 · 2022: $283 · 2023: $432 · 2024: $613 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,648.72 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $875.70 | 2019-2025 | Luxor, Centurion, Rocklatan |
| Glaukos Corporation | $622.03 | 2023-2025 | Idosetr, Idose, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Ivantis, INC | $369.53 | 2019-2021 | |
| Allergan, INC. | $168.02 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $134.50 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $116.80 | 2022-2025 | Lumigan, Alphagan P, Xen Glaucoma Treatment System |
| Novartis Pharmaceuticals Corporation | $73.58 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $65.67 | 2019-2021 | |
| Rxsight INC | $64.77 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Regeneron Healthcare Solutions, INC. | $54.04 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $53.03 | 2024-2025 | Cirrus Hd-Oct |
| Tarsus Pharmaceuticals, INC. | $50.15 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $44.78 | 2025 | Vabysmo |
| Carl Zeiss Meditec, INC. | $41.56 | 2021 | |
| Sun Pharmaceutical Industries INC. | $36.86 | 2019-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.66 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $31.46 | 2021 | |
| Iridex Corporation | $25.50 | 2019 | |
| Derma Sciences, INC. | $20.01 | 2019 | |
| Shire North American Group INC | $16.23 | 2019 | |
| Sight Sciences, INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Battle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.